EASD 2025 15 - 19 September 2025

Continuous glucose monitoring-based outcomes in adults with type 2 diabetes receiving IcoSema vs comparators: post hoc analysis of COMBINE 1 and 3

Authors :

Concetta Irace¹; Vanja Cejvanovic²; Jonas H Larsen³; Thaís MP Rocha²; Yasuo Terauchi⁴; Chantal Mathieu⁵

Affiliations

View Details Hide Details

{{ getPageNum(PDFPage) }}

Keywords

Diabetes

Congress short oral presentation

Insulin

IcoSema (Icodec Semaglutide)

PHASE 3 (RCT)